Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Claude M Rwigema

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Cancers|July 13, 2024
Testing and Validation of a Custom Retrained Large Language Model for the Supportive Care of HN Patients with External Knowledge BaseLibing Zhu, Yi Rong, Lisa A McGee, et al.
Cancer Investigation|April 25, 2017
Re-Irradiation Therapy for Locally Recurrent Head and Neck Cancer: A National Survey of Practice PatternsJean-Claude M Rwigema, Jehee Choi, Nancy Y Lee, et al.
Chinese Clinical Oncology|August 11, 2016
Cost-comparativeness of proton versus photon therapyVivek Verma, Chirag Shah, Jean-Claude M Rwigema, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 25, 2017
Systematic assessment of clinical outcomes and toxicities of proton radiotherapy for reirradiationVivek Verma, Jean-Claude M Rwigema, Robert S Malyapa, et al.
Acta Oto-Laryngologica|September 14, 2017
Predictors of prolongation in radiation treatment time in a veteran population treated with chemoradiation for oropharyngeal cancerAndrew M Vahabzadeh-Hagh, Jean-Claude M Rwigema, Vishad Nabili, et al.
Cancers|June 26, 2025
Improving the Precision of Deep-Learning-Based Head and Neck Target Auto-Segmentation by Leveraging Radiology Reports Using a Large Language ModelLibing Zhu, Jean-Claude M Rwigema, Xue Feng, et al.
Clinical Lung Cancer|March 6, 2014
Incidental mediastinal dose does not explain low mediastinal node recurrence rates in patients with early-stage NSCLC treated with stereotactic body radiotherapyJean-Claude M Rwigema, Allen M Chen, Pin-Chieh Wang, et al.
Practical Radiation Oncology|November 22, 2014
Stereotactic body radiation therapy for abdominal and pelvic oligometastases: Dosimetric targets for safe and effective local controlJean-Claude M Rwigema, Christopher King, Pin-Chieh Wang, et al.
American Journal of Clinical Oncology|August 6, 2010
Concurrent cetuximab with stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: a single institution matched case-control studyDwight E Heron, Jean-Claude M Rwigema, Michael K Gibson, et al.
Journal of Cancer Research and Therapeutics|November 24, 2012
Clinical outcomes of reirradiation of brain metastases from small cell lung cancer with Cyberknife stereotactic radiosurgeryAdam C Olson, Rodney E Wegner, Jean Claude M Rwigema, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Cancers|July 13, 2024
Testing and Validation of a Custom Retrained Large Language Model for the Supportive Care of HN Patients with External Knowledge BaseLibing Zhu, Yi Rong, Lisa A McGee, et al.
Cancer Investigation|April 25, 2017
Re-Irradiation Therapy for Locally Recurrent Head and Neck Cancer: A National Survey of Practice PatternsJean-Claude M Rwigema, Jehee Choi, Nancy Y Lee, et al.
Chinese Clinical Oncology|August 11, 2016
Cost-comparativeness of proton versus photon therapyVivek Verma, Chirag Shah, Jean-Claude M Rwigema, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 25, 2017
Systematic assessment of clinical outcomes and toxicities of proton radiotherapy for reirradiationVivek Verma, Jean-Claude M Rwigema, Robert S Malyapa, et al.
Acta Oto-Laryngologica|September 14, 2017
Predictors of prolongation in radiation treatment time in a veteran population treated with chemoradiation for oropharyngeal cancerAndrew M Vahabzadeh-Hagh, Jean-Claude M Rwigema, Vishad Nabili, et al.
Cancers|June 26, 2025
Improving the Precision of Deep-Learning-Based Head and Neck Target Auto-Segmentation by Leveraging Radiology Reports Using a Large Language ModelLibing Zhu, Jean-Claude M Rwigema, Xue Feng, et al.
Clinical Lung Cancer|March 6, 2014
Incidental mediastinal dose does not explain low mediastinal node recurrence rates in patients with early-stage NSCLC treated with stereotactic body radiotherapyJean-Claude M Rwigema, Allen M Chen, Pin-Chieh Wang, et al.
Practical Radiation Oncology|November 22, 2014
Stereotactic body radiation therapy for abdominal and pelvic oligometastases: Dosimetric targets for safe and effective local controlJean-Claude M Rwigema, Christopher King, Pin-Chieh Wang, et al.
American Journal of Clinical Oncology|August 6, 2010
Concurrent cetuximab with stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: a single institution matched case-control studyDwight E Heron, Jean-Claude M Rwigema, Michael K Gibson, et al.
Journal of Cancer Research and Therapeutics|November 24, 2012
Clinical outcomes of reirradiation of brain metastases from small cell lung cancer with Cyberknife stereotactic radiosurgeryAdam C Olson, Rodney E Wegner, Jean Claude M Rwigema, et al.
Pageof 7